Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity. Cates ZP, Facciuolo A, Scruten E, Kusalik A, et al. PLoS One 2025;20:e0330741.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cates ZP, Facciuolo A, Scruten E, Kusalik A, et al. Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity. PLoS One 2025;20:e0330741.
PMID: 40906715